Literature DB >> 10858828

The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes.

H Fielding1, N Kyaterekera, G G Skellern, J N Tettey, J R McDade, Z Msuya, D G Watson, J Urie.   

Abstract

Varying concentrations of octreotide acetate (Sandostatin) and diamorphine hydrochloride were prepared and stored in polypropylene syringes at 37 degrees C in the dark. The solutions were analysed for octreotide acetate content using a validated HPLC method at regular intervals over a 48-h period. The results indicate that octreotide acetate remains stable in the presence of diamorphine hydrochloride at 37 degrees C for 24 h. In addition, the solutions prepared maintained their clarity, with no signs of precipitation upon visual examination under normal light conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858828     DOI: 10.1191/026921600666997498

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  2 in total

1.  Stability of octreotide acetate decreases in a sodium bisulfate concentration-dependent manner: compatibility study with morphine and metoclopramide injections.

Authors:  Kouichi Tanabe; Junko Wada; Jun Ohkubo; Atsumi Nitta; Tomoaki Ikezaki; Miyako Takeuchi; Aya Handa; Mai Tanaka; Nozomu Murakami; Tatsuhiko Kashii; Hidenori Kitazawa
Journal:  Eur J Hosp Pharm       Date:  2015-01-16

Review 2.  The current evidence base for the feasibility of 48-hour continuous subcutaneous infusions (CSCIs): A systematically-structured review.

Authors:  James Baker; Andrew Dickman; Stephen Mason; John Ellershaw
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.